Cell Culture Contamination

Cell Culture Contamination

This is the first in a three-part series on CO2 incubation. Biological contamination is the dread of every person working with cell culture. Find out how to avoid it

Written byDouglas Wernerspach andMary Kay Bates
Updated | 7 min read
Register for free to listen to this article
Listen with Speechify
0:00
7:00

Understanding the Causes and Managing the Risks

This is the first in a three-part series on COincubation

Biological contamination is the dread of every person working with cell culture. When cultures become infected with microorganisms, or cross-contaminated by foreign cells, these cultures usually must be destroyed. Since the sources of culture contamination are ubiquitous as well as difficult to identify and eliminate, no cell culture laboratory remains unaffected by this concern. With the continuing increase in the use of cell culture for biological research, vaccine production, and production of therapeutic proteins for personalized medicine and emerging regenerative medicine applications, culture contamination remains a highly important issue.

Introduction

Cell culture is continuing a 60-year trend of increasing use and importance in academic research, therapeutic medicine, and drug discovery, accompanied by an amplified economic impact.1,2 New therapies, vaccines, and drugs, as well as regenerated and synthetic organs, will increasingly come from cultured mammalian cells. With greater usage and proficiency of cell culture techniques comes a better understanding of the perils and problems associated with cell culture contamination. In the 21st century, there are better testing methods and preventive tools, and an awareness of the risk and effects of contamination requires that cell culturists remain vigilant; undetected contamination can have widespread downstream effects.

Biological contamination: a common companion

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.

About the Authors

  • Douglas Wernerspach is the senior business director/general manager—CO2 incubators and biological safety cabinets at Thermo Fisher Scientific. In his role, he manages a portfolio of global market-leading CO2 incubators and biological safety cabinets, with a focus on business development, innovative product design, and operational excellence within research, academic, and cell and gene therapy industries. A seasoned life science leader, Douglas has spent 30 years working at Thermo Fisher Scientific, where he has used his deep knowledge of global markets and technical expertise to develop innovative new solutions. He earned a Bachelor of Science in Microbiology from Rutgers University, as well as a Master of Business Administration from the University of Connecticut. He can be reached at douglas.wernerspach@thermofisher.com

    View Full Profile
  • Mary Kay Bates is a senior global cell culture scientist with Thermo Fisher Scientific, where she provides cell culture and equipment expertise to colleagues and customers across laboratory and cleanroom settings, as well as at conferences. Her knowledge is based on 20 years of experience in academic and industrial cell and molecular biology labs, focusing on cancer and gene therapy. Mary Kay holds an M.S. in microbiology from the University of Wisconsin-Madison and has authored numerous publications. She can be reached at marykay.bates@thermofisher.com.

    View Full Profile

Related Topics

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image